The safety and efficacy of Methylene Blue MMX modified release tablets administered to subjects undergoing screening or surveillance colonoscopy.

Trial Profile

The safety and efficacy of Methylene Blue MMX modified release tablets administered to subjects undergoing screening or surveillance colonoscopy.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Methylthioninium chloride-Cosmo (Primary)
  • Indications Adenoma; Colon cancer
  • Focus Diagnostic use; Registrational
  • Sponsors Cosmo Pharmaceuticals
  • Most Recent Events

    • 31 Jan 2017 Status changed to completed.
    • 28 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.
    • 28 Jul 2016 Planned primary completion date changed from 1 May 2016 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top